Back to results
US 8,278,268 B2Granted
Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
AssigneeOrtho-McNeil Pharmaceutical, Inc.
InventorsJacqueline C. Bussolari, Xiaoli Chen, Bruce R. Conway, Keith T. Demarest, Hamish N. M. Ross, Rafael Severino
Life of this patent
Estimating the term…
Abstract
Combination therapy comprising PPAR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.
Claims29
A method for treating diabetes or Syndrome X in a subject, said method comprising
- (a) administering to said subject a jointly effective amount of a glucose reabsorption inhibitor;
- and
- (b) administering to said subject a jointly effective amount of a PPAR modulator,
- said co-administration being in any order and the combined jointly effective amounts providing the desired therapeutic effect and a reduction in a side effect associated with the PPAR modulator administered alone.
1 more element
A method for treating diabetes, Syndrome X, or associated symptoms or complications thereof in a subject, said method comprising
- (a) administering to said subject a jointly effective amount of a glucose reabsorption inhibitor;
- and
- (b) administering to said subject a jointly effective amount of a PPAR modulator,
- said co-administration being in any order and the combined jointly effective amounts providing the desired therapeutic effect and a reduction in a side effect associated with the PPAR modulator administered alone;
- and wherein said diabetes, Syndrome X, or associated symptoms or complications thereof is selected from the group consisting of IDDM, NIDDM, IGT, IFG, obesity, nephropathy, neuropathy, retinopathy, atherosclorosis, polycystic ovary syndrome or polycystic ovarian syndrome, hypertension, ischemia, stroke, heart disease, irritable bowel disorder, inflammation, and cataracts.
2 more elements
Dependencies are inferred from the claim text.